Mind Medicine (MindMed) Inc. (MNMD)
NASDAQ: MNMD · Real-Time Price · USD
6.55
-0.19 (-2.82%)
At close: Jun 27, 2025, 4:00 PM
6.63
+0.08 (1.22%)
After-hours: Jun 27, 2025, 7:53 PM EDT
Mind Medicine (MindMed) Market Cap
Mind Medicine (MindMed) has a market cap or net worth of $494.87 million as of June 27, 2025. Its market cap has decreased by -8.56% in one year.
Market Cap
494.87M
Enterprise Value
304.47M
1-Year Change
-8.56%
Ranking
Category
Stock Price
$6.55
Market Cap Chart
Since March 4, 2020, Mind Medicine (MindMed)'s market cap has decreased from $595.37M to $494.87M, a decrease of -16.88%. That is a compound annual growth rate of -3.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 494.87M | -3.04% |
| Dec 31, 2024 | 510.39M | 247.80% |
| Dec 29, 2023 | 146.75M | 77.54% |
| Dec 30, 2022 | 82.66M | -85.99% |
| Dec 31, 2021 | 590.17M | -82.89% |
| Dec 31, 2020 | 3.45B | 479.23% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.15B |
| Johnson & Johnson | 366.71B |
| AbbVie | 322.03B |
| Novo Nordisk | 304.96B |
| UnitedHealth Group | 280.41B |
| Novartis AG | 235.85B |
| Abbott Laboratories | 233.80B |
| AstraZeneca | 217.42B |